Scholarlink

Abstract <p>Multidrug-resistant (MDR) <i>Pseudomonas</i><i> aeruginosa</i> poses a critical challenge in clinical settings because of its resistance to conventional antibiotics. This study investigated the antibacterial potential of silica-coated silver nanoparticles (SiO₂@AgNPs) against MDR <i>P. aeruginosa</i> and explored their synergistic interactions with selected antibiotics. A total of 450 pus samples were processed for bacterial isolation, and <i>P. aeruginosa</i> was identified using standard microbiological methods. MDR strains were confirmed using MIC-based VITEK antimicrobial susceptibility testing and RT-PCR for resistance genes. The antibacterial activity of the SiO₂@AgNPs was assessed using the microbroth dilution method. A checkerboard assay was conducted against MDR isolates to determine the synergy between SiO₂@AgNPs and ciprofloxacin, meropenem, and ceftazidime-avibactam. The synthesized nanoparticles were characterized using transmission electron microscopy (TEM), Fourier-transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD) analysis. Of the 450 pus samples, 100 <i>P. aeruginosa</i> isolates were identified, of which 13 were classified as MDR <i>P. aeruginosa</i>. SiO₂@AgNPs exhibited effective antibacterial activity, with an MIC of 500&#xa0;µg/mL against MDR <i>P. aeruginosa</i>. Checkerboard assays demonstrated strong synergy with meropenem and ceftazidime-avibactam (FICI = 0.375) and partial synergy with ciprofloxacin (FICI = 0.625–1.0625). TEM revealed spherical particles with an average size of 10&#xa0;nm, FTIR confirmed SiO₂ functional groups, and XRD revealed crystalline silver nanoparticles within an amorphous silica matrix. These findings indicate that SiO₂@AgNPs possess potent antibacterial activity against MDR <i>P. aeruginosa</i> and can enhance the efficacy of certain antibiotics, highlighting their potential in combination therapy against resistant strains.</p> Key points <p>● <i>Silica-coated silver nanoparticles effectively inhibited MDR P. aeruginosa.</i></p> <p><i>● SiO₂@AgNPs enhance the efficacy of meropenem and ceftazidime-avibactam.</i></p> <p>●<i> Nanoparticle-antibiotic combinations may offer new strategies for treating resistant infections.</i></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Harnessing silica-coated silver nanoparticles for combating multidrug-resistant Pseudomonas aeruginosa

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月10日

查看全文
  • Salma Banu. A,
  • Jaya Lakshmi. S. S.,
  • Leela K. V.,
  • K. Mani Rahulan,
  • Kaviyarasan. S

摘要

Abstract

Multidrug-resistant (MDR) Pseudomonas aeruginosa poses a critical challenge in clinical settings because of its resistance to conventional antibiotics. This study investigated the antibacterial potential of silica-coated silver nanoparticles (SiO₂@AgNPs) against MDR P. aeruginosa and explored their synergistic interactions with selected antibiotics. A total of 450 pus samples were processed for bacterial isolation, and P. aeruginosa was identified using standard microbiological methods. MDR strains were confirmed using MIC-based VITEK antimicrobial susceptibility testing and RT-PCR for resistance genes. The antibacterial activity of the SiO₂@AgNPs was assessed using the microbroth dilution method. A checkerboard assay was conducted against MDR isolates to determine the synergy between SiO₂@AgNPs and ciprofloxacin, meropenem, and ceftazidime-avibactam. The synthesized nanoparticles were characterized using transmission electron microscopy (TEM), Fourier-transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD) analysis. Of the 450 pus samples, 100 P. aeruginosa isolates were identified, of which 13 were classified as MDR P. aeruginosa. SiO₂@AgNPs exhibited effective antibacterial activity, with an MIC of 500 µg/mL against MDR P. aeruginosa. Checkerboard assays demonstrated strong synergy with meropenem and ceftazidime-avibactam (FICI = 0.375) and partial synergy with ciprofloxacin (FICI = 0.625–1.0625). TEM revealed spherical particles with an average size of 10 nm, FTIR confirmed SiO₂ functional groups, and XRD revealed crystalline silver nanoparticles within an amorphous silica matrix. These findings indicate that SiO₂@AgNPs possess potent antibacterial activity against MDR P. aeruginosa and can enhance the efficacy of certain antibiotics, highlighting their potential in combination therapy against resistant strains.

Key points

● Silica-coated silver nanoparticles effectively inhibited MDR P. aeruginosa.

● SiO₂@AgNPs enhance the efficacy of meropenem and ceftazidime-avibactam.

● Nanoparticle-antibiotic combinations may offer new strategies for treating resistant infections.